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Abstract
Background
Papillary lesions of the breast constitute a heterogeneous group ranging from non-malignant
papillomas to papillary carcinoma. While surgical excision is recommended for atypical
papilloma or papillary DCIS/ carcinoma on core biopsy, controversy persists in the
management of benign papillomas which are diagnosed with core needle biopsy (CNB) since
there are variable reported rates for tumor upgrade. The purpose of this study was to determine
the outcome of papillary lesions of the breast diagnosed at image-guided CNB, after surgical
excision or follow-up, and to identify potential predictors of high-risk lesions/malignancy on
imaging.

Materials and methods
We retrospectively identified 52 non-malignant papillary lesions on core biopsy between
January 2012 and June 2018. The outcome of surgical excision, as well as clinical and imaging
features of these lesions, were assessed. The final histologic upgrade was recorded, and
variables were compared between benign and atypical lesions on core biopsy as well as between
upgraded and non-upgraded lesions after surgical excision.

Results
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Thirty-six lesions out of 52 lesions were benign papillomas on core biopsy, while 16 were
papillary lesions with ADH/DCIS. All of these lesions except four benign papillomas were
excised. Of the 32 benign papillomas excised, 7 were upgraded to papilloma with ADH/DCIS
and one to DCIS with the focus of invasion. Among the 16 atypical lesions excised, one was
upgraded to papillary DCIS with a final upgrade rate of 17.3%. There was no statistically
significant clinical or imaging feature among those that were upgraded on excision from those
that were not upgraded.

Conclusion
Non-malignant papillary lesions have a significant upgrade rate. There are no reliable clinical
or imaging features that can pre-surgically predict upgrade. Therefore, surgical excision of all
papillary lesions is recommended for definitive diagnosis.
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Introduction
Papillary breast lesions comprise a broad spectrum ranging from benign/atypical papillomas to
papillary carcinoma in situ/carcinoma [1]. The reported incidence is up to 6% on core needle
biopsy (CNB) specimen [2-4].
The imaging and/or clinical features often pose a diagnostic challenge and cannot reliably
predict the benign or malignant nature of the lesion. The initial diagnosis is usually established
through a percutaneous biopsy, but the reported false-negative rate is around 3% to 10%. Also,
the malignancy rate in papillomas with atypical hyperplasia is about 17% to 67% [5]. The
heterogeneity of papillomas as well as under-sampling may account for these observations.
While there is consensus that surgical excision is imperative when an atypical papilloma or
papillary DCIS/ carcinoma is identiﬁed at CNB, controversy persists in the management of
benign papillomas diagnosed at CNB [6]. The published literature supporting their excision
reports upgrade rates of 0% to 29% [7]. On the other hand, several authors report either no or
minimal upgrade rate and recommend follow-up rather than excision [8]. The decision to evade
or pursue surgical excision is crucial as an unwarranted excision leads to potential morbidity
and increases healthcare costs. This is especially relevant in our setup as patients pay out of
their own pockets and have limited resources. Also, missing a potential malignancy is
undesirable as often the patients do not return for follow-up or surveillance due to lack of a
proper health system and poor resources.
Therefore, in this study, we intended to determine the outcome of papillary lesions of the
breast diagnosed at image-guided CNB after surgical excision or follow-up and compared the
ultrasound features of benign and atypical papillary lesions as well as those with the upgrade,
thereby identifying the potential predictors of high-risk lesions/malignancy.

Materials And Methods
After approval from the Institutional Ethical Review Committee, the surgical pathology
database of the Section of Histopathology, Aga Khan University Hospital was searched for cases
reported as "Intra-ductal Papilloma", "Intra-ductal Papilloma with ADH," and "Intra-ductal
Papilloma with DCIS" between January 2012 and June 2018, through “Integrated Laboratory
Management System (ILMS)” software.
Cases in which the papillary lesion was identified as an additional finding of invasive carcinoma
or cases in which papillary lesion was mixed with other benign proliferative lesions and was
difficult to identify as a separate and distinct lesion were excluded. We identified 96 patients
(Figure 1). Fifty-five patients were further excluded as they had no prior imaging (n=9), no
image-guided core biopsy at our institute (n=42), and had neither surgery nor follow-up
imaging available (n=4). Finally, 52 lesions in 41 patients constituted the study population.
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FIGURE 1: Flow chart showing patients with intraductal
papillomas

All core biopsies were performed under ultrasound guidance with a 14-gauge needle and
spring-loaded biopsy gun (Magnum, Bard, Covington, GA) after informed consent. Three to five
cores were obtained from each lesion. The core biopsy as well as surgical excision specimens
were reviewed by an experienced breast pathologist.
All papillary lesions with ADH or DCIS underwent surgical excision. Benign intra-ductal
papillomas either underwent excision (n = 32) or follow-up (n=4) at the discretion of the
referring surgeon.
The final histopathology after surgical excision was recorded. The lesions which were benign on
initial core biopsy were deemed upgraded if they showed ADH/DCIS on excision. The papillary
lesions with ADH or DCIS on initial core biopsy were considered upgraded if they showed
papillary DCIS or invasive malignancy after excision.
All statistical analyses were performed using SPSS version 20.0 software. The independent ttest was used to compare continuous variables like age and lesion size, while Chi-square and
Fisher’s exact tests were used to compare categorical variables among patients who had benign
papillomas with those who had atypia on core biopsy as well as between upgraded and nonupgraded lesions after surgical excision. Two-tailed p-values were calculated. Results with a pvalue of less than 0.05 were considered statistically significant.

Results
A total of 52 non-malignant papillary lesions were found on core biopsy in 41 patients over a
six-year period. The mean patient age was 50.8 years (ranging from 21 to 83 years) and the
mean lesion size was 13 mm (ranging from 4 to 37 mm).
Seven patients had multiple lesions, while the rest had a solitary lesion.
Thirty-six lesions were classified as benign papillomas while 16 were papillary lesions with
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ADH/DCIS. All these lesions except four benign papillomas were excised. Three of the benign
papillomas that were not excised were followed for 12 months and they showed either decrease
in size or disappeared. The fourth one remained unchanged on follow-up (24 months).
The initial pathology at core biopsy and the final pathology at surgical excision are shown in
Table 1.

Histologic findings at surgical excision
Histologic findings at core biopsy
Benign

ADH/DCIS

Papillary DCIS

DCIS with focus of invasion

Benign papillomas that went excision (n = 32)

24

7

0

1

Atypical papillomas (n = 16)

1

14

1

0

TABLE 1: Histologic findings of non-malignant papillary lesions on core biopsy and
surgical excision
ADH, atypical ductal hyperplasia; DCIS, ductal carcinoma in situ

Of the 32 benign papillomas excised, seven were found to be atypical (papilloma with
ADH/DCIS) and one lesion was upgraded to DCIS with the focus of invasion. Among the 16
atypical lesions excised, one was upgraded to papillary DCIS and one was downgraded to
benign papilloma and the rest were unchanged. The final upgrade rate including the four nonexcised ones as benign was 17.3%.
Out of 52 papillary lesions, 14 (26.9%) had a palpable mass. Nipple discharge was also present
in 14 patients (26.9%), out of which eight had blood discharge. There was a history of either
contralateral or ipsilateral malignancy in six patients (11%). On mammography, a mass was
detectable in 14 patients (26.9%) and calcification in one patient, while seven patients (13.4%)
had either architectural distortion or an indistinct density. In 28 patients, no obvious
abnormality was seen on a mammogram due to heterogeneously dense parenchyma. One
patient did not undergo a mammogram as she was less than 30 years old and in one patient, a
mammogram was not available.
On ultrasound, 29 lesions (55.7%) were intra-ductal, out of which 23 were retro-areolar/central,
i.e. within 2 centimeters of the nipple while six of the intra-ductal lesions were peripherally
located. The total number of peripherally located lesions was 23 (44.2%) out of the total 52
lesions. Circumscribed margins on ultrasound were seen in 44 (84.6%) patients.
The majority of the lesions with homogeneous echotexture were benign, 31 versus seven
atypical lesions (Figure 2). This feature showed a statistical significance with p-value of 0.001.
The rest of the clinical and imaging features were not statistically significant among benign
and atypical lesions.
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FIGURE 2: (A) A homogeneous isoechoic solid intraductal
nodule (white star) within the dilated duct (long white arrows).
Focal vascularity noted within the intraductal nodule (thick
short white arrow). (B) The dilated duct (white arrow) is seen
extending to the retro-areolar region. The intraductal nodule
proved to be benign papilloma on core biopsy as well as
surgical excision.

The clinical and imaging characteristics of benign and atypical lesions on core biopsy are
shown in Table 2.

Characteristics

Benign (n=36)

Atypia (n=16)

p-value

Mean age (years)

49.3

49.1

0.96

Mean size (millimeters)

12.5

12.8

0.87

Clinical

Palpable mass

1.00

Yes

10

04

No

26

12

Nipple discharge

0.50

Yes

11

03

No

25

13

Contralateral/ ipsilateral malignancy
Yes
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No

32

14

Mammographic findings
Mass

1.00

Yes

10

04

No

26

12

Architectural distortion/indistinct density

0.41

Yes

06

01

No

30

15

Ultrasound findings
Intraductal lesion

0.24

Yes

22

07

No

14

09

Vascularity

1.00

Yes

28

13

No

08

03

Location

0.96

Central (within 2 cm from nipple)

20

09

Peripheral

16

07

Echotexture

0.001

Homogeneous

31

07

Heterogeneous

05

09

Margins

0.08

Circumscribed

33

11

Irregular

03

05

TABLE 2: Clinical and imaging characteristics of benign and atypical papillary lesions
diagnosed on core biopsy

There was no statistically significant difference in the clinical or imaging features of lesions
that were upgraded on excision from those that were not upgraded. Although all upgraded
lesions had vascularity on ultrasound, 32 (74.4 %) out of 43 non-upgraded lesions also had
vascularity and this feature had an insignificant p value of 0.17. Table 3 summarizes the results
of comparison of clinical and imaging features of lesions with histological upgrade to those
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without upgrade after surgical excision.

Characteristics

Upgrade (n=9)

Non- upgrade (n=43)

p-value

Mean age (years)

52.8

48.5

0.33

Mean size (millimeters)

10.5

13

0.30

Clinical

Palpable mass

0.13

Yes

01

17

No

08

26

Nipple discharge

0.68

Yes

03

11

No

06

32

Contralateral/ ipsilateral malignancy

1.00

Yes

01

05

No

08

38

Mammographic findings
Mass

1.00

Yes

02

12

No

07

31

Architectural distortion/indistinct density

0.59

Yes

02

05

No

07

38

Ultrasound findings
Intraductal lesion

1.00

Yes

05

24

No

04

19

Vascularity

0.17

Yes

09

32

No

00

11

Location
Central (within 2 cm from nipple)

0.74
06
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Peripheral

03

20

Echotexture

0.41

Homogeneous

08

30

Heterogeneous

01

13

Margins

1.00

Circumscribed

08

36

Irregular

01

07

Core biopsy result

0.24

Atypia

01

15

Benign

08

28

TABLE 3: Clinical and imaging characteristics of upgraded and non-upgraded lesions
on excision

Discussion
Papillary lesions of the breast are rare, benign papillary lesions representing approximately 10%
of breast lesions and invasive papillary carcinoma accounting for only 2% of breast cancer. The
diagnosis of papillary lesions is challenging on needle biopsy and sometimes even on excision
biopsy, and this has led to controversial and challenging management of these lesions.
Excision has been recommended for papillary lesions with ADH/ALH or atypia as these may be
associated with cancer, while for lesions without atypia, the same is not recommended [9]. The
underestimation of papillary lesions as reported in a meta-analysis was 15.7% and they found a
statistically significant difference of underestimation rate between two groups, i.e. before 2005
vs. 2007 or later (OR 1.974, 95% CI 1.06-3.69) [10]. The improvement in diagnosis was
contributed to factors like biopsies under image guidance and immunohistochemistry
supporting the pathologist. The upgrade rate in the present study was 17.3%. In a study by Wang
et al., the reported upgrade rate of benign /atypical papillary lesions was higher (25%); their
study population was primarily African American [11].
The papillary lesions diagnosed on imaging can undergo core biopsy (14 or a 16G needle) or
vacuum-assisted Mammotome (MT) biopsy using an 11G needle. It may be difficult to
distinguish benign papillary lesion from malignant on core biopsy if only a small part of the
lesion is available for pathological review as it depends on the presence or absence of
myoepithelial cell layer of the lesion’s papillary component [12]. Hence, insufficient sampling
can be one of the factors contributing to the underestimation of papillary lesion especially if a
vacuum-assisted larger bore needle is not used. In our study, US-guided 14-G for lesions was
performed and may account for the upgrade on subsequent excision.
Due to the reported upgrade rate to cancer, researchers have focused to find the cause of this
discrepancy [13-14]. The present study also evaluated a number of demographical and
radiological factors for correlation with the upgrade of papillary lesions. The average age of
patients with upgraded lesions was 52.8 years which was more than that of patients without
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upgrading (48.5years), showing results similar to those of Wang et al. although it was not
statistically significant [11].
The study by Kil et al. showed two features more frequently with atypical and malignant
papillary lesions than benign lesions, i.e. peripheral location and size of more than 1.5 cm;
these features were not seen in the present study [1]. The size of the papilloma was also
evaluated for the likelihood of malignancy by Glenn et al.; however, no correlation with the size
of the lesion was seen in their study [15]. Hence, the size threshold for surgical excision cannot
be recommended.
Although great efforts have been made to determine the predictive value of a number of clinical
and imaging features for up-gradation of papillary lesions on excisional biopsy, the conclusions
from these studies vary significantly [16-18]. In the present study, none of the clinical features
showed statistical significance in predicting the upgrade of the lesion.
Small retro areolar papillomas are often difficult to identify on mammography. Larger lesions
may appear as circumscribed round or oval masses with or without calcification [19-20]. In our
study, more than half of the lesions (53.8%) were not discernable on mammograms due to
heterogeneously dense parenchyma. The mammographic features observed in the remaining
cases were either mass or an indistinct density. Calcification was a very rare feature, seen only
in one case. None of the mammographic features showed statistical significance for predicting
atypia or upgrade.
The typical ultrasound features of a benign intraductal papilloma are a solid nodule within a
dilated duct in the subareolar location [21]. In the present study, out of total 28 non-upgraded
benign papillomas, 13 were peripherally located, among which seven were not intraductal.
Also, five of the upgraded benign papillomas were retro areolar as well as intraductal. Similarly,
more than half of the atypical papillomas (56.2%), including the ones with upgrades were retro
areolar. Hence, this feature too cannot reliably differentiate benign from atypical papilloma.
The other sonographic features of papillary breast lesions suspicious for malignancy include
irregular, non-circumscribed mass, non-parallel to the skin, complex echo pattern, posterior
acoustic shadowing, or a combination of features [22]. In the present study, although the
majority of benign papillomas were circumscribed, the p-value was not statistically significant
(0.08). Another significant finding, i.e. posterior acoustic shadowing, was not observed in any
lesion whether benign, atypical, or malignant. The only sonographic feature which showed a
statistical significance (p-value, 0.001) among benign and atypical papillomas was echotexture.
Most of the lesions with homogeneous echotexture were benign. However, the implication of
this is uncertain as all eight benign papillomas that were finally upgraded also had
homogeneous echotexture. We, therefore, recommend surgical excision of all non-malignant
papillary lesions.
This study has a few limitations; first, this is a single-center study; second, this has a small
sample size due to the rarity of papillary lesions of the breast. Further multicenter studies are
thus required for the determination of clinical and imaging risk factors associated with the
underestimation of these lesions.

Conclusions
Non-malignant papillary breast lesions show significant upgrade on excision whether they are
benign papillomas or those with atypia. There are no reliable clinical or imaging features that
can predict the upgrade or accurately differentiate benign from atypical papillary lesions presurgery. The inadequate sampling on core biopsy is an unavoidable persistent issue and
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continues to account for underestimation. We therefore recommend surgical excision of all
papillary lesions diagnosed on core biopsy for definitive evaluation.
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